Mankind Pharma's healthcare camp at the Mahakumbh 2025 in Prayagraj, Uttar Pradesh, will continue through to 26 Jan daily from 12 pm to 4pm

The partnership between Mankind Pharma and Innovent Biologics offers a pivotal solution, aiming to tackle the rising incidence of cancer

Mankind Pharma, India’s 4th largest pharmaceutical co, announced its financial results for the second quarter and six months ended 30 Sep

Mankind Pharma Limited has completed the transaction to acquire 100% stake in BSV for INR 13,768 Crores

Mankind Pharma to acquire a 100% stake in Bharat Serums and Vaccines Limited (BSV) from Advent International (“Advent”) for INR 13,630 Cr

The agreement with Takeda allows Mankind Pharma to launch the novel drug for treating Gastroesophageal Reflux Disease under its trademark

Under their CSR arm, the company is committed to making a meaningful impact in regions affected by leprosy.